<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">Using cryo-electron microscopy, a number of studies, including Walls et al.
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>, determined structures of the spike. These resembled most closely the structure of the SARS-CoV spike. As seen for other coronaviruses, two conformations were visualized — a closed state, with the RBDs docked against the trimeric core, and an open conformation with a single RBD raised into its ‘up’ position
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. These studies also showed, just like SARS-CoV, that SARS-CoV-2 uses ACE2 for human cell entry
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. A crystal structure soon followed, showing how the RBD binds to ACE2 (ref.
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>
 </sup>). Shortly after this, the first structure of a neutralizing antibody bound to the RBD of the spike glycoprotein showed that SARS-CoV-reactive antibodies could neutralize the new virus
 <sup>
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup>, and polyclonal antibody sera against SARS-CoV also proved effective
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. In many ways, these structural studies showed that the new virus resembles a virus that causes SARS; a true SARS-CoV-2.
</p>
